Anixa Biosciences, Inc.
NASDAQ:ANIX · NASDAQ Capital Market
+$0.10 today
Vol 0.59M · Avg 0.12M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-13.91%
Period High
$5.22
Period Low
$2.35
Latest
$2.91
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Opus Genetics, Inc.
NASDAQ:IRD
$338.16M
TuHURA Biosciences, Inc.
NASDAQ:HURA
$149.97M
Acumen Pharmaceuticals, Inc.
NASDAQ:ABOS
$137.30M
Spero Therapeutics, Inc.
NASDAQ:SPRO
$127.38M
Agenus Inc.
NASDAQ:AGEN
$123.05M
Seer, Inc.
NASDAQ:SEER
$94.84M
Entera Bio Ltd.
NASDAQ:ENTX
$60.13M
Inovio Pharmaceuticals, Inc.
NASDAQ:INO
$58.15M
Actuate Therapeutics Inc
NASDAQ:ACTU
$49.29M
VistaGen Therapeutics, Inc.
VTGN
$22.92M
What is the latest ANIX filing?
The latest filing shown is 4 dated Jun 17, 2026.
How many recent filings does ANIX have?
Intrinsic Alpha currently shows 20 recent filings for ANIX.
Explore More
Continue the stock analysis
Jump to another research area for this company.